Interleukin 17A (IL17A) Antibody

Este producto es parte de IL17A - Interleukin 17A
Product Graph
364€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Interleukin 17A (IL17A) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx234224
tested applications
ELISA, WB, IHC

Description

IL17A Antibody is a Rabbit Polyclonal against IL17A.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetInterleukin 17A (IL17A)
HostRabbit
ReactivityHuman, Mouse, Rat
Recommended DilutionWB: 1/500 - 1/2000, IHC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationUnconjugated
IsotypeIgG
Purity≥ 95% (SDS-PAGE)
PurificationPurified by immunogen affinity chromatography.
Size 1100 µg
FormLiquid
Tested ApplicationsELISA, WB, IHC
BufferPBS, pH 7.3, with 0.02% sodium azide and 50% glycerol.
AvailabilityShipped within 5-12 working days.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDQ16552
AliasIL17,CTLA8,IL-1,ILA17,CTLA-8,IL-17A
BackgroundAntibody anti-IL17A
StatusRUO
NoteConcentration: 2 mg/ml - Validity: 12 months.

Descripción

IL17A is a pro-inflammatory cytokine produced primarily by T-helper 17 (Th17) cells and other immune cells in response to infection and tissue damage IL17A plays a central role in innate and adaptive immunity by stimulating the production of chemokines, cytokines, and antimicrobial peptides that recruit neutrophils and enhance host defense against bacterial and fungal infections Dysregulated IL17A production is associated with autoimmune diseases such as psoriasis, rheumatoid arthritis, and inflammatory bowel disease, where it contributes to chronic inflammation and tissue damage IL17A also plays a role in cancer, where it can promote tumor growth and metastasis by inducing angiogenesis, immune suppression, and chronic inflammation IL17A-targeted therapies, including monoclonal antibodies such as secukinumab, have been developed to treat autoimmune and inflammatory conditions by neutralizing IL17A activity and reducing inflammation

Related Products

abx137011

Interleukin 17E (IL17E) Antibody

Interleukin 17E (IL17E) Antibody is a Mouse Monoclonal antibody against Interleukin 17E (IL17E).

Ver Producto
abx313227

Interleukin 17A (IL17A) Antibody (HRP)

IL17A Antibody (HRP) is a Rabbit Polyclonal against IL17A conjugated to HRP.

Ver Producto
abx490887

Cow Interleukin 17A (IL17A) CLIA Kit

Cow Interleukin 17A (IL17A) Chemiluminescent Immunoassay (CLIA) Kit is a Sandwich Chemiluminescent Immunoassay (CLIA) Kit for use with Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Ver Producto